Issue navigation
Volume 59, Issue 3, March 2020
EDITORIALS
The jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece?
Rheumatology, Volume 59, Issue 3, March 2020, Pages 459–461, https://doi.org/10.1093/rheumatology/kez492
Addressing the hardest endpoint
Rheumatology, Volume 59, Issue 3, March 2020, Pages 462–463, https://doi.org/10.1093/rheumatology/kez514
Drug initiation and escalation strategies of vasodilator therapies for Raynaud’s phenomenon: can we treat to target?
Rheumatology, Volume 59, Issue 3, March 2020, Pages 464–466, https://doi.org/10.1093/rheumatology/kez522
Are cardiovascular events and mortality in patients with systemic lupus erythematosus predictable at diagnosis?
Rheumatology, Volume 59, Issue 3, March 2020, Pages 467–468, https://doi.org/10.1093/rheumatology/kez539
REVIEWS
Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen
Rheumatology, Volume 59, Issue 3, March 2020, Pages 469–477, https://doi.org/10.1093/rheumatology/kez572
Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 478–486, https://doi.org/10.1093/rheumatology/kez644
GUIDELINE
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary
Rheumatology, Volume 59, Issue 3, March 2020, Pages 487–494, https://doi.org/10.1093/rheumatology/kez664
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
Rheumatology, Volume 59, Issue 3, March 2020, Pages e1–e23, https://doi.org/10.1093/rheumatology/kez672
CLINICAL SCIENCE
Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus
Rheumatology, Volume 59, Issue 3, March 2020, Pages 495–504, https://doi.org/10.1093/rheumatology/kez288
Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study
Rheumatology, Volume 59, Issue 3, March 2020, Pages 505–512, https://doi.org/10.1093/rheumatology/kez371
Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4–related disease
Rheumatology, Volume 59, Issue 3, March 2020, Pages 513–518, https://doi.org/10.1093/rheumatology/kez321
IL-16 expression is increased in the skin and sera of patients with systemic sclerosis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 519–523, https://doi.org/10.1093/rheumatology/kez318
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
Rheumatology, Volume 59, Issue 3, March 2020, Pages 524–533, https://doi.org/10.1093/rheumatology/kez292
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus
Rheumatology, Volume 59, Issue 3, March 2020, Pages 534–544, https://doi.org/10.1093/rheumatology/kez306
Significant association between clinical characteristics and immuno-phenotypes in patients with ANCA-associated vasculitis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 545–553, https://doi.org/10.1093/rheumatology/kez327
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature
Rheumatology, Volume 59, Issue 3, March 2020, Pages 554–558, https://doi.org/10.1093/rheumatology/kez334
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 559–567, https://doi.org/10.1093/rheumatology/kez277
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years
Rheumatology, Volume 59, Issue 3, March 2020, Pages 568–574, https://doi.org/10.1093/rheumatology/kez324
Nurse-led care is preferred over GP-led care of gout and improves gout outcomes: results of Nottingham Gout Treatment Trial follow-up study
Rheumatology, Volume 59, Issue 3, March 2020, Pages 575–579, https://doi.org/10.1093/rheumatology/kez333
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study
Rheumatology, Volume 59, Issue 3, March 2020, Pages 580–585, https://doi.org/10.1093/rheumatology/kez322
Predictive factors for sustained remission with stratification by myositis-specific autoantibodies in adult polymyositis/dermatomyositis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 586–593, https://doi.org/10.1093/rheumatology/kez328
Top down or bottom up? An observational investigation of improvement in fibromyalgia symptoms following hip and knee replacement
Rheumatology, Volume 59, Issue 3, March 2020, Pages 594–602, https://doi.org/10.1093/rheumatology/kez303
Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis—results from a JIA biologic registry
Rheumatology, Volume 59, Issue 3, March 2020, Pages 603–612, https://doi.org/10.1093/rheumatology/kez309
Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes
Rheumatology, Volume 59, Issue 3, March 2020, Pages 613–621, https://doi.org/10.1093/rheumatology/kez330
Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension
Rheumatology, Volume 59, Issue 3, March 2020, Pages 622–633, https://doi.org/10.1093/rheumatology/kez336
Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients
Rheumatology, Volume 59, Issue 3, March 2020, Pages 634–640, https://doi.org/10.1093/rheumatology/kez280
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry
Rheumatology, Volume 59, Issue 3, March 2020, Pages 641–649, https://doi.org/10.1093/rheumatology/kez340
Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c
Rheumatology, Volume 59, Issue 3, March 2020, Pages 650–661, https://doi.org/10.1093/rheumatology/kez293
BASIC AND TRANSLATIONAL SCIENCE
Human osteoarthritic synovial fluid increases excitability of mouse dorsal root ganglion sensory neurons: an in-vitro translational model to study arthritic pain
Rheumatology, Volume 59, Issue 3, March 2020, Pages 662–667, https://doi.org/10.1093/rheumatology/kez331
STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE
Rheumatology, Volume 59, Issue 3, March 2020, Pages 668–677, https://doi.org/10.1093/rheumatology/kez354
LETTERS TO THE EDITOR
OTHERS
Temporal artery biopsy: audit of histological diagnosis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 678–679, https://doi.org/10.1093/rheumatology/kez396
Why is the frequency of uveitis low in Turkish children with juvenile idiopathic arthritis?
Rheumatology, Volume 59, Issue 3, March 2020, Pages 679–680, https://doi.org/10.1093/rheumatology/kez399
CASE REPORTS
Cardiac troponin T: is there a cut-off to exclude cardiac involvement in the idiopathic inflammatory myopathies?
Rheumatology, Volume 59, Issue 3, March 2020, Pages 681–682, https://doi.org/10.1093/rheumatology/kez319
A case of haemorrhagic myositis with concurrent anti-Ro52 and anti-NXP-2 antibodies treated with plasmapheresis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 682–684, https://doi.org/10.1093/rheumatology/kez365
A patient with predominant interstitial nephritis as a renal manifestation of systemic lupus erythematosus
Rheumatology, Volume 59, Issue 3, March 2020, Pages 685–687, https://doi.org/10.1093/rheumatology/kez401
The first case of monozygotic twin boys with nearly identical features of Sjögren’s syndrome
Rheumatology, Volume 59, Issue 3, March 2020, Pages 687–688, https://doi.org/10.1093/rheumatology/kez428
MATTERS ARISING
Comment on: Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus
Rheumatology, Volume 59, Issue 3, March 2020, Pages 688–689, https://doi.org/10.1093/rheumatology/key385
Comment on: How to use bisphosphonates safely and optimally
Rheumatology, Volume 59, Issue 3, March 2020, Pages 689–690, https://doi.org/10.1093/rheumatology/kez097
Comment on: Comorbidity burden in axial spondyloarthritis: a cluster analysis
Rheumatology, Volume 59, Issue 3, March 2020, Pages 690–692, https://doi.org/10.1093/rheumatology/kez593
Comment on: Comorbidity burden in axial spondyloarthritis: a cluster analysis: reply
Rheumatology, Volume 59, Issue 3, March 2020, Pages 692–693, https://doi.org/10.1093/rheumatology/kez573
CLINICAL VIGNETTES
An unusual cause of deforming erosive arthritis in an adult
Rheumatology, Volume 59, Issue 3, March 2020, Page 602, https://doi.org/10.1093/rheumatology/kez312
Crowned dens syndrome; a diagnostic thorn
Rheumatology, Volume 59, Issue 3, March 2020, Page 694, https://doi.org/10.1093/rheumatology/kez339
Gouty arthritis mutilans: obvious but ignored on two occasions
Rheumatology, Volume 59, Issue 3, March 2020, Page 695, https://doi.org/10.1093/rheumatology/kez342
Calcinosis cutis of the face, mandible and neck
Rheumatology, Volume 59, Issue 3, March 2020, Page 696, https://doi.org/10.1093/rheumatology/kez367
CORRIGENDUM
Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus
Rheumatology, Volume 59, Issue 3, March 2020, Page 697, https://doi.org/10.1093/rheumatology/kez433
ERRATUM
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
Rheumatology, Volume 59, Issue 3, March 2020, Page 698, https://doi.org/10.1093/rheumatology/kez516
